Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-01-08 Sale | 2021-01-11 5:59 pm | Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer | 3,000 | $33.94 | $101,820 | 218,171 (Direct) | View |
| 2020-12-08 Sale | 2020-12-10 4:16 pm | Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer | 3,000 | $33.78 | $101,327 | 221,171 (Direct) | View |
| 2020-11-09 Sale | 2020-11-12 5:00 pm | Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer | 3,000 | $32.96 | $98,892 | 224,171 (Direct) | View |
| 2020-10-08 Sale | 2020-10-09 4:12 pm | Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer | 3,000 | $33.53 | $100,576 | 227,171 (Direct) | View |
| 2020-09-14 Sale | 2020-09-16 6:09 pm | Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer | 3,000 | $31 | $93,000 | 230,171 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-15 Option Award | 2024-05-17 4:14 pm | N/A 2034-05-14 | Stoke Therapeutics Inc. | STOK | Leggett Thomas Chief Financial Officer | 396,200 | $0 | 396,200 (Direct) | View |
Ownership | 2021-03-17 9:45 pm | N/A N/A | Research Alliance Corp. II | RACB | Leggett Thomas Director | 0 | $0 | 30,000 (Direct) | View |
| 2021-02-17 Option Award | 2021-02-19 6:47 pm | N/A 2031-02-16 | Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-11 5:59 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer | 3,000 | $10.86 | 218,171 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-11 5:59 pm | N/A 2029-09-08 | Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer | 3,000 | $0 | 218,171 (Direct) | View |
| 2020-12-08 Exercise | 2020-12-10 4:16 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer | 3,000 | $10.86 | 221,171 (Direct) | View |
| 2020-12-08 Exercise | 2020-12-10 4:16 pm | N/A 2029-09-08 | Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer | 3,000 | $0 | 221,171 (Direct) | View |
| 2020-11-09 Exercise | 2020-11-12 5:00 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer | 3,000 | $10.86 | 224,171 (Direct) | View |
| 2020-11-09 Exercise | 2020-11-12 5:00 pm | N/A 2029-09-08 | Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer | 3,000 | $0 | 224,171 (Direct) | View |
| 2020-10-08 Exercise | 2020-10-09 4:12 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer | 3,000 | $10.86 | 227,171 (Direct) | View |
| 2020-10-08 Exercise | 2020-10-09 4:12 pm | N/A 2029-09-08 | Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer | 3,000 | $0 | 227,171 (Direct) | View |
| 2020-09-14 Exercise | 2020-09-16 6:09 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer | 3,000 | $10.86 | 230,171 (Direct) | View |
| 2020-09-14 Exercise | 2020-09-16 6:09 pm | N/A 2029-09-08 | Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer | 3,000 | $0 | 230,171 (Direct) | View |
| 2020-01-29 Option Award | 2020-01-31 4:55 pm | N/A 2030-01-29 | Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer | 55,540 | $0 | 55,540 (Direct) | View |
Ownership | 2020-01-29 8:03 pm | N/A 2029-09-08 | Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer | 0 | $0 | 288,711 (Direct) | View |